Xenetic
Xenetic is a Massachusetts-based biopharmaceutical company that develops and commercializes T cell immunotherapies for the treatment of cancer.
Business Model:
Revenue: $1.6M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Xenetic Information
Geographic Data
Address: 945 Concord Street
City: Framingham
State: MA
Zip: 01701
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$13M
Raised Total:$47M
Social
Metrics
8,115,522Website Global Rank
518Website Monthly Traffic
Twitter Followers
Description
Xenetic is a Massachusetts-based biopharmaceutical company that develops and commercializes T cell immunotherapies for the treatment of cancer.
Contact Phone:
+17817787720
Contact Email:
Xenetic went public on 10/11/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/11/2013
Ticker Symbol:
XBIO
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2014 | Post-IPO Equity | 1 | $10M |
Baxter International Baxter International Baxter International |
7/2015 | Convertible Note | $3M | 7/2021 | Post-IPO Equity | $12.5M | 12/2020 | Post-IPO Equity | $6M | 10/2022 | Post-IPO Equity | $488.8k |
Unicorn Capital Partners |
10/2022 | Post-IPO Equity | $488.8k | 4/2022 | Post-IPO Equity | $866.3k | 7/2019 | Post-IPO Equity | $15M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
